½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > ÆäËû¿¹Ìå > PRAME ¿¹Ô­£¨ÖØ×éµ°°×£©

²úÆ·ÖÐÐÄ

×îвúÆ·

  • PRAME ¿¹Ô­£¨ÖØ×éµ°°×£©

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW17542
    • Ó¦Óà : ½ö¹©¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º100ug
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·

ÖÐÎÄÃû³Æ£º  PRAME ¿¹Ô­£¨ÖØ×éµ°°×£©

Ó¢ÎÄÃû³Æ£º PRAME Antigen (Recombinant Protein)

±ð      Ãû£º preferentially expressed antigen in melanoma; MAPE; OIP4; CT130; OIP-4

´¢      ´æ£º Àä¶³£¨-20¡æ£©

Ïà¹ØÀà±ð£º ¿¹Ô­

¸ÅÊö

Fusion protein corresponding to a region derived from 260-509 amino acids of human PRAME


¼¼Êõ¹æ¸ñ

Full name:

preferentially expressed antigen in melanoma

Synonyms:

MAPE; OIP4; CT130; OIP-4

Swissprot:

P78395

Gene Accession:

BC014074

Purity:

>85%, as determined by Coomassie blue stained SDS-PAGE

Expression system:

Escherichia coli

Tags:

His tag C-Terminus, GST tag N-Terminus

Background:

This gene encodes an antigen that is preferentially expressed in human melanomas and that is recognized by cytolytic T lymphocytes. It is not expressed in normal tissues, except testis. The encoded protein acts as a repressor of retinoic acid receptor, and likely confers a growth advantage to cancer cells via this function. Alternative splicing results in multiple transcript variants.


¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿